Mini-Board 2014 Flashcards
All of the following indicate apoptosis EXCEPT ___.
a. Agarose gel electrophoresis: Distinct bands of oligonucleosomes
b. Microscopic: Pyknosis, karyolysis, and karyorrhexis
c. Sequelae: Stromal collapse
d. Ultrastructural: Zeiosis
B; PBVD:17,26; R&C:27; HRW:16
Which of the following is a self-transmissible, but not self-replicating, mobile genetic
element that encodes machinery for integration into or excision from the bacterial
chromosome?
a. Plasmid
b. Bacteriophage
c. Pathogenicity island
d. Integrative and conjugative element
D; Vet Pathol 51(2):328-340, 2014
Which of the following is a platelet-derived mediator with procoagulant effects?
a. Plasminogen activator inhibitor-1
b. Tissue factor pathway inhibitor
c. Platelet-derived growth factor
d. Protease nexin II
A; PBVD:70
In the complement cascade, plasma properdin extends the half-life of otherwise labile \_\_\_. a. C4b2b b. C3bBb c. C3bBb3b d. Activated C1
B; Toxicol Pathol 40:174, 2012; PBVD: 105
The CD115 ligand that controls proliferation, differentiation, and survival of monocytes is \_\_\_. a. GM-CSF b. TGF-β c. CSF-1 d. IL3
C; PBVD:250
Efferocytosis induces the generation of all of the following EXCEPT ___.
a. TGF-β
b. NFκB
c. VEGF
d. IL-10
B; Toxicol Pathol 40:169, 2012
In reference to horizontal bacterial gene transfer, transformation is ___.
a. the transfer of a plasmid from a donor bacterium through a pilus
b. the uptake of free environmental DNA from dead bacteria
c. direct transfer of a plasmid via bacteria-bacteria contact
d. injection of DNA into a bacterium by a bacteriophage
B; PBVD:164-5; Vet Pathol 51(2):328-340, 2014
Superantigens cross-link ___ to the T-cell receptor, resulting in ___ T-cell activation.
a. MHC class I; polyclonal
b. MHC class II; polyclonal
c. MHC class I; monoclonal
d. MHC class II; monoclonal
B; Toxicol Pathol 40(2):224, 2012; PBVD fig. 5-25
Which of the following is a multiprotein complex that prevents access of DNA repair proteins to telomeres? a. Telomerase b. Shelterin c. Rubicon d. Sirtuin
B; Cell 153(6):1198, 2013
A single base pair substitution that produces a change in a single amino acid that
significantly alters the function of the translated protein is a ___.
a. Missense mutation
b. Nonsense mutation
c. Frameshift mutation
d. Single nucleotide polymorphism
A; R&C: 138; PBVD:53
A low-dose toxin that triggers beneficial effects that surpass the repair of the triggering
damage and contributes to improved cellular fitness elicits a ___ response.
a. Nonthreshold linear
b. Nonmonotonic
c. Threshold
d. Hormetic
D; Cell 153(6):1204, 2013; Casarett & Doull’s
Toxicology 8th ed., p. 25
All of the following are types of CD4+FoxP3+ regulatory T-cells EXCEPT ___ cells.
a. nTREG
b. iTREG
c. TH3
d. Tr1
D; Toxicol Pathol 40:188, 2012
Which is FALSE regarding ceroid and lipofuscin?
a. Lipofuscin derives from autophagy, whereas ceroid derives from heterophagy
b. Both pigments autofluoresce, and are positive for, Sudan black, and oil-red-O
c. Ceroid is only intracellular, whereas lipofuscin is intra- and/or extracellular
d. Ceroid is usually deleterious, whereas lipofuscin is not
C; PBVD:42-44
Which of the following promotes the phosphorylation and ubiquitination of β-catenin?
a. TCF
b. WNT
c. GSK3β
d. E-cadherin
C; PBVD:293
Under the influence of thrombin, endothelium becomes activated to produce all of the following mediators EXCEPT \_\_\_. a. PDGF b. TXA2 c. tPA d. NO
B; PBVD: 73
The endothelial lateral border recycling compartment contains all of the following EXCEPT \_\_\_. a. CD99 b. JAM-A c. Nepmucin d. VE-cadherin
D; Vet Pathol 50(1):7-22, 2013
Prostaglandin E2 (PGE2) inhibits ___.
a. Cell proliferation
b. Tumor angiogenesis
c. Metastatic potential
d. Normal immune response
D; Vet Pathol 48(1):255, 2011
Which is the most common major fibril protein type in amyloid of aging?
a. AA
b. Aβ
c. APP
d. IAPP
B; PBVD:286-287
Which of the following is a host cell receptor for foot and mouth disease virus?
a. VP1
b. VP2
c. Vβ3
d. NSP4
C; PBVD:211
Which disease is the result of a primary cytotoxic hypersensitivity?
a. Myasthenia gravis
b. Polyarteritis nodosa
c. Type I diabetes mellitus
d. Systemic lupus erythematosus
A; R&C:203-206; PBVD:264-265